Atlas Trials

Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease

Clinical trial NCT00006077 · COMPLETED

Trial details

NCT number
NCT00006077
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2000-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.